The cytoskeletal adapter protein spinophilin regulates invadopodia dynamics and tumor cell invasion in glioblastoma

Molecular Cancer Research

Volumn 14, Issue 12, 2016, Pages 1277-1287

  Cheerathodi, Mujeeburahiman ^a   Avci, Naze G ^a   Guerrero, Paola A ^a   Tang, Leung K ^b   Popp, Julia ^b   Morales, John E ^a   Chen, Zhihua ^a   Carnero, Amancio ^c   Lang, Frederick F ^c   Ballif, Bryan A ^d   Rivera, Gonzalo M ^b   McCarty, Joseph H ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c CSIC   (Spain)

^d UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHAVBETA8 INTEGRIN; INTEGRIN; RAC1 PROTEIN; SPINOPHILIN; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; INTEGRIN ALPHAVBETA8; NERVE PROTEIN; NEURABIN; PROTEIN BINDING; RAC1 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CANCER GROWTH; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE TARGETING; GLIOBLASTOMA; GLIOBLASTOMA CELL LINE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PODOSOME; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; REGULATORY MECHANISM; TUMOR INVASION; ANIMAL; BRAIN TUMOR; CANCER TRANSPLANTATION; CELL ADHESION; CELL MOTION; CHEMISTRY; HUMAN; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; BINDING SITES; BRAIN NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; GLIOBLASTOMA; HUMANS; INTEGRINS; MICE; MICROFILAMENT PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NERVE TISSUE PROTEINS; PODOSOMES; PROTEIN BINDING; RAC1 GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION;

EID: 85004039818     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-16-0251     Document Type: Article

References (50)

1. Louis DN. Molecular pathology of malignant gliomas. Ann Rev Pathol 2006;1:97-117.
2. Wang D, Anderson JC, Gladson CL. The role of the extracellular matrix in angiogenesis in malignant glioma tumors. Brain Pathol 2005;15:318-26.
3. Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT. Angiogenesis in brain tumours. Nat Rev Neurosci 2007;8:610-22.
4. Hynes RO. The extracellular matrix: not just pretty fibrils. Science 2009;326:1216-9.
5. Kim C, Ye F, Ginsberg MH. Regulation of integrin activation. Annu Rev Cell Dev Biol 2011;27:321-45.
6. Parsons JT, Horwitz AR, Schwartz MA. Cell adhesion: integrating cytoskeletal dynamics and cellular tension. Nat Rev Mol Cell Biol 2010;11:633-43.
7. Weis SM, Cheresh DA. alphaV integrins in angiogenesis and cancer. Cold Spring Harb Perspect Med 2011;1:a006478.
8. Nishimura SL, Sheppard D, Pytela R. Integrin alpha v beta 8. Interaction with vitronectin and functional divergence of the beta 8 cytoplasmic domain. J Biol Chem 1994;269:28708-15.
9. Worthington JJ, Klementowicz JE, Travis MA. TGFbeta: a sleeping giant awoken by integrins. Trends Biochem Sci 2010;36:47-54.
10. Allinson K, Lee H, Fruttiger M, McCarty J, Arthur H. Endothelial expression of TGFβ type II receptor is required to maintain vascular integrity during postnatal development of the central nervous system. PLoS ONE 2012;7: e39336.
11. Arnold TD, Ferrero GM, Qiu H, Phan IT, Akhurst RJ, Huang EJ, et al. Defective retinal vascular endothelial cell development as a consequence of impaired integrin alphaVbeta8-mediated activation of transforming growth factor-beta. J Neurosci 2012;32:1197-206.
12. McCarty JH, Lacy-Hulbert A, Charest A, Bronson RT, Crowley D, Housman D, et al. Selective ablation of alphav integrins in the central nervous system leads to cerebral hemorrhage, seizures, axonal degeneration and premature death. Development 2005;132:165-76.
13. Mobley AK, Tchaicha JH, Shin J, Hossain MG, McCarty JH. {beta}8 integrin regulates neurogenesis and neurovascular homeostasis in the adult brain. J Cell Sci 2009;122:1842-51.
14. Nguyen HL, Lee YJ, Shin J, Lee E, Park SO, McCarty JH, et al. TGF-beta signaling in endothelial cells, but not neuroepithelial cells, is essential for cerebral vascular development. Lab Invest 2011;91:1554-63.
15. Proctor JM, Zang K, Wang D, Wang R, Reichardt LF. Vascular development of the brain requires beta8 integrin expression in the neuroepithelium. J Neurosci 2005;25:9940-8.
16. Tchaicha JH, Mobley AK, Hossain MG, Aldape KD, McCarty JH. A mosaic mouse model ofastrocytoma identifies alphavbeta8 integrin as a negative regulator of tumor angiogenesis. Oncogene 2010;29:4460-72.
17. Tchaicha JH, Reyes SB, Shin J, Hossain MG, Lang FF, McCarty JH. Glioblastoma angiogenesis and tumor cell invasiveness are differentially regulated by beta8 integrin. Cancer Res 2011;71:6371-81.
18. Schittenhelm J, Klein A, Tatagiba MS, Meyermann R, Fend F, Goodman SL, et al. Comparing the expression of integrins alphavbeta3, alphavbeta5, alphavbeta6, alphavbeta8, fibronectin and fibrinogen in human brain metastases and their corresponding primary tumors. Int J Clin Exp Pathol 2013;6:2719-32.
19. McCarty JH, Cook AA, Hynes RO. An interaction between {alpha}v{beta} 8 integrin and Band 4.1B via a highly conserved region of the Band 4.1 C-terminal domain. Proc Natl Acad Sci U S A 2005;102:13479-83.
20. Garcia-Mata R, Boulter E, Burridge K. The 'invisible hand': regulation of RHO GTPases by RHOGDIs. Nat Rev Mol Cell Biol 2011;12:493-504.
21. Reyes SB, Narayanan AS, Lee HS, Tchaicha JH, Aldape KD, Lang FF, et al. alphavbeta8 integrin interacts with RhoGDI1 to regulate Rac1 and Cdc42 activation and drive glioblastoma cell invasion. Mol Biol Cell 2013;24:474-82.
22. Lee HS, Cheerathodi M, Chaki SP, Reyes SB, Zheng Y, Lu Z, et al. Protein tyrosine phosphatase-PEST and beta8 integrin regulate spatiotemporal patterns of RhoGDI1 activation in migrating cells. Mol Cell Biol 2015;35:1401-13.
23. Sarrouilhe D, di Tommaso A, Metaye T, Ladeveze V. Spinophilin: from partners to functions. Biochimie 2006;88:1099-113.
24. Feng J, Yan Z, Ferreira A, Tomizawa K, Liauw JA, Zhuo M, et al. Spinophilin regulates the formation and function of dendritic spines. Proc Natl Acad Sci U S A 2000;97:9287-92.
25. Baucum AJ II, Jalan-Sakrikar N, Jiao Y, Gustin RM, Carmody LC, Tabb DL, et al. Identification and validation of novel spinophilin-associated proteins in rodent striatum using an enhanced ex vivo shotgun proteomics approach. Mol Cell Prot 2010;9:1243-59.
26. Peti W, Nairn AC, Page R. Structural basis for protein phosphatase 1 regulation and specificity. FEBS J 2013;280:596-611.
27. Bielas SL, Serneo FF, Chechlacz M, Deerinck TJ, Perkins GA, Allen PB, et al. Spinophilin facilitates dephosphorylation of doublecortin by PP1 to mediate microtubule bundling at the axonal wrist. Cell 2007; 129:579-91.
28. Carnero A. Spinophilin: a new tumor suppressor at 17q21. Curr Mol Med 2012;12:528-35.
29. Sonoda Y, Ozawa T, Aldape KD, Deen DF, Berger MS, Pieper RO. Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma. Cancer Res 2001;61:6674-8.
30. Verhaak RG, Valk PJ. Genes predictive of outcome and novel molecular classification schemes in adult acute myeloid leukemia. Cancer Treat Res 2010;145:67-83.
31. Holland EC, Celestino J, Dai C, Schaefer L, Sawaya RE, Fuller GN. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet 2000;25:55-7.
32. Seano G, Primo L. Podosomes and invadopodia: tools to breach vascular basement membrane. Cell Cycle 2015;14:1370-4.
33. Destaing O, Block MR, Planus E, Albiges-Rizo C. Invadosome regulation by adhesion signaling. Curr Opin Cell Biol 2011;23:597-606.
34. Moshfegh Y, Bravo-Cordero JJ, Miskolci V, Condeelis J, Hodgson L. A Trio-Rac1-Pak1 signalling axis drives invadopodia disassembly. Nat Cell Biol 2014;16:574-86.
35. Ryan XP, Alldritt J, Svenningsson P, Allen PB, Wu GY, Nairn AC, et al. The Rho-specific GEF Lfc interacts with neurabin and spinophilin to regulate dendritic spine morphology. Neuron 2005;47:85-100.
36. Aoki K, Matsuda M. Visualization of small GTPase activity with fluorescence resonance energy transfer-based biosensors. Nat Protoc 2009;4:1623-31.
37. Ferrer I, Verdugo-Sivianes EM, Castilla MA, Melendez R, Marin JJ, Munoz-Galvan S, et al. Loss of the tumor suppressor spinophilin (PPP1R9B) increases the cancer stem cell population in breast tumors. Oncogene 2016;35:2777-88.
38. Schwarzenbacher D, Stiegelbauer V, Deutsch A, Ress AL, Aigelsreiter A, Schauer S, et al. Low spinophilin expression enhances aggressive biological behavior of breast cancer. Oncotarget 2015;6:11191-202.
39. Estevez-Garcia P, Lopez-Calderero I, Molina-Pinelo S, Munoz-Galvan S, Salinas A, Gomez-Izquierdo L, et al. Spinophilin loss correlates with poor patient prognosis in advanced stages of colon carcinoma. Clin Cancer Res 2013;19:3925-35.
40. Ress AL, Stiegelbauer V, Schwarzenbacher D, Deutsch A, Perakis S, Ling H, et al. Spinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancer. Oncotarget 2014;5:8492-502.
41. Ferrer I, Blanco-Aparicio C, Peregrina S, Canamero M, Fominaya J, Cecilia Y, et al. Spinophilin acts as a tumor suppressor by regulating Rb phosphorylation. Cell Cycle 2011;10:2751-62.
42. Stephens DJ, Banting G. In vivo dynamics of the F-actin-binding protein neurabin-II. Biochem J 2000;345:185-94.
43. Lee HJ, Zheng JJ. PDZ domains and their binding partners: structure, specificity, and modification. Cell Commun Sig 2010;8:8.
44. Kim C, Ye F, Ginsberg MH. Regulation of integrin activation. Ann Rev Cell Develop Biol 2011;27:321-45.
45. Jannuzi AL, Bunch TA, West RF, Brower DL. Identification of integrin beta subunit mutations that alter heterodimer function in situ. Mol Biol Cell 2004;15:3829-40.
46. Drappatz J, Norden AD, Wen PY. Therapeutic strategies for inhibiting invasion in glioblastoma. Expert Rev Neurotherap 2009;9:519-34.
47. Ferrara N, Hillan KJ, Gerber HP, Novotny W. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 2004;3:391-400.
48. Bergers G, Hanahan D. Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 2008;8:592-603.
49. Paez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Vinals F, et al. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 2009;15:220-31.
50. McCarty JH. Glioblastoma resistance to anti-VEGF therapy: has the challenge been MET? Clin Cancer Res 2013;19:1631-3.